We expect Novo to gain $75 billion of a more than $200 billion global GLP-1 market in diabetes and obesity by 2031, ahead of semaglutide's 2032 patent expiration, with Lilly standing as the firm's key ...

Advanced Fertility Center of Chicago (AFCC), a premier provider of comprehensive and best-in-class fertility services, congratulates Dr. Michelle Catenacci on being named a 2025 Castle Connolly Top ...

AgelessRx, a pioneer in longevity and telehealth solutions, announced the introduction of oral sublingual drops for GLP-1 receptor agonists Semaglutide and Tirzepatide. By offering non-injectable ...

Huxley Medical, a commercial-stage medical technology firm focused on streamlining detection of sleep and heart disorders, announced that the US Food and Drug Administration (FDA) has cleared the ...

A woman who has suffered with sleep apnoea for a decade is finally able to breathe and sleep again thanks to a new implant.

Americans will soon have access to an infusion device that provides round-the-clock effective relief of Parkinson's disease.

All lines have been placed on mute to prevent any background noise. There will be a question-and-answer session at the ...